New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

How a good mood could help some vaccines work better - An elevated mood could boost the effectiveness of vaccines with newer ...

Researchers found antibodies in those who reported the most positive moods were 16% higher when compared to those with lowest ...

The Eurozone March CPI rose +2.2% y/y, right on expectations and the slowest pace of increase in 5 months. The March core CPI rose +2.4% y/y, weaker than expectations of +2.5% y/y and the smallest ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...

Running a 2,000 patient study, with average risk patients in the U.S., to read out by the end of 2025 (eAArly DETECT 2). With ...

Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure Pharmaceuticals Ltd. for the ...

U.S. stock futures point lower as investors await tomorrow's announcement on reciprocal tariffs, and OpenAI announces a $40 ...

Disturbing news appears nearly daily from the federal government. Among the science-related issues, the most disturbing was ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...